Results 101 to 110 of about 483,449 (145)

[Network pharmacology-based investigation of the therapeutic efficacy and molecular targets of Xiangsha Liujunzi decoction in thyroid carcinoma]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Huang K, Liu Y, Liang R, Zheng G, Zhu L, Song F, Guo Y.   +6 more
europepmc   +1 more source

[Ecological analysis of the association between dietary factors and thyroid carcinoma incidence based on GBD 2021 data]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Chen K, Duan Y, Xu J.
europepmc   +1 more source

Graves病患者血清可溶性白细胞介素2受体水平与甲状腺激素的关系

, 1996
比较Ｇｒａｖｅｓ病患者血清可溶性白细胞介素２受体（ｓＩＬ－２Ｒ）水平及其与甲状腺素（Ｔ４）、三碘甲腺原氨酸（Ｔ３）和促甲状腺激素（ＴＳＨ）等水平的相关性。结果显示：甲状腺机能亢进症未治疗组血清ｓＩＬ－２Ｒ明显升高；１２例Ｇｒａｖｅｓ病患者经抗甲状腺药物治疗后ｓＩＬ－２Ｒ明显降低；Ｇｒａｖｅｓ眼病经治疗临床甲亢症状缓解组血清ｓＩＬ－２Ｒ无明显改变；血清ｓＩＬ－２Ｒ与Ｔ３、Ｔ４呈正相关，与ＴＳＨ呈负相关。提示除了自身免疫功能紊乱外，甲状腺激素水平可能对Ｇｒａｖｅｓ病患者血清ｓＩＬ ...

core  

碘难治性分化型甲状腺癌靶向药物不良反应管理专家共识（2018年版）

Zhongguo aizheng zazhi, 2018
<正>碘难治性分化型甲状腺癌（radioactive iodine-refractory differentiated thyroid cancer,RAIR-DTC）广义上包括:聚碘能力丧失或促甲状腺激素（thyroid-stimulating hormone,TSH）受体表达降低的分化型甲状腺癌、未分化甲状腺癌及甲状腺髓样癌。由于RAIR-DTC对放射性131I、TSH抑制剂治疗及放化疗均不敏感 ...
doaj  

Infra-slow body-surface potentials show a group-level association with thyroid cancer. [PDF]

J Zhejiang Univ Sci B
Deng B, Zhang R, Liu Y, Lin J, Gui S, Wei X, Cheng Y, Zheng L, Hu S, Lyu P, Li Y, Wang H.   +11 more
europepmc   +1 more source

[Intrathyroid thymic carcinoma: report of a case]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Lai X, Xu Z, Wu C, Wang X, Zhou X, Qiu J.   +5 more
europepmc   +1 more source

[Diffuse large B-cell lymphoma of thyroid invading the superior mediastinum with hashimoto's thyroiditis: a case report and literature review]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2023
Lv J, Yu T, Yin W.
europepmc   +1 more source

[A nomogram combining ultrasound radiomics and clinical features for predicting pathological invasiveness of papillary thyroid carcinoma]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Liu H, Hou C, Wei M, Lu K, Sun L, Tang J.   +5 more
europepmc   +1 more source

[Impact of optimizing the quality control system on newborn screening outcomes for congenital hypothyroidism]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Wang J, Qi ZY, Zhong QH, Jiang YH, Wang Q, Zhao XL, Duan J.   +6 more
europepmc   +1 more source

[Preparation of retinoic acid and irinotecan co-loaded lipo-somes and their <i>in vitro</i> evaluation against anaplastic thyroid carcinoma]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Lyu S, Zhou Y, Xu Y, Yang F.
europepmc   +1 more source